Live Breaking News & Updates on Novartis Ag Stock Exchange
Stay updated with breaking news from Novartis ag stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic. | June 15, 2023 ....
Ad hoc announcement pursuant to Art. 53 LR Chinook Therapeutics is a clinical-stage biopharmaceutical company with two high-value, late-stage assets in development for IgA nephropathy , a rare,. | June 12, 2023 ....
Survey of Unmet Needs in chronic myeloid leukemia data signal need for amplified patient voice during treatment discussions that balance quality of life , efficacy, and. | June 9, 2023 ....
Novartis s off-patent medicines division Sandoz set out its growth plans as a standalone company following the proposed spinoff, saying it is well positioned to continue. | June 8, 2023 ....
European shares opened lower on Thursday as rate-sensitive technology shares slipped on expectations of further interest rate hikes by major central banks, although gains in Swiss healthcare group. | June 8, 2023 ....